When combined with the induction of cell‐mediated immunity, it is advantageous that TPA are able to induce immunity at the site of the tumour, which involves key anti‐tumour players such as CD8+ T cells and NK cells, without stimulating cells involved in tumour immunosuppression (Ribatti, 2017). Here, CD8A is linked to neoplasm.